Back to trial details

Intake questionnaire

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Applying to Northwestern University · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Solid Tumor, Adult?
3. Are you able to travel to Chicago for study visits?